Sufficient sleep linked to increased odds of combined flourishing measure, individual measures.
Compared with other therapies alone, including psychotherapy, antidepressant medication, exercise, or therapy, chronotherapy was more effective at days 5 to 7.
Findings seen in large study of patients with restless leg syndrome starting dopamine agonists.
Cognitive behavioral therapy (CBT) may reduce the incidence of insomnia symptoms in adolescents, according to study data presented at the 2019 World Sleep Congress.
Researchers assessed the impact of a 30- or 90-minute nap on individuals with major depressive disorder.
Study suggests an unfavorable association of early-life behavioral problems with adulthood sleep health, underlining the importance of treating behavioral problems in children and addressing insomnia from a life-course perspective.
Patients with chronic pain may perceive improvements in pain, sleep, anxiety, and depression with the use of hemp-derived cannabidiol oil.
The FDA has rejected the supplemental New Drug Application for Hetlioz (tasimelteon; Vanda Pharmaceuticals) for the treatment of jet lag disorder.
The Food and Drug Administration (FDA) approved Wakix (pitolisant; Harmony Biosciences) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.
Overall, US older adults who reported longer sleep duration have poorer objective and subjective cognitive performance.